Finance

Lists
Q2 2026 earnings • released • EPS miss -4.41% • Revenue miss -6.47%
See results
PNVL3:BVMF
Dimed SA Distribuidora de Medicamentos
R$11.98
-1.32%
(-0.16) 1D
Aug 10, 5:05:56 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PNVL3...
Open
R$12.14
High
R$12.14
Low
R$11.85
Mkt. cap
1.79B
Avg. vol.
685.77K
Volume
496.80K
Dividend
2.75%
Quarterly dividend
R$0.08
Ex-dividend date
Apr 29, 2015
P/E ratio
13.65
52-wk high
R$16.30
52-wk low
R$8.76
EPS
R$0.88
Shares outstanding
150.38M
No. of employees
11K
Open
R$12.14
High
R$12.14
Low
R$11.85
Mkt. cap
1.79B
Avg. vol.
685.77K
Volume
496.80K
Dividend
2.75%
Quarterly dividend
R$0.08
Ex-dividend date
Apr 29, 2015
P/E ratio
13.65
52-wk high
R$16.30
52-wk low
R$8.76
EPS
R$0.88
Shares outstanding
150.38M
No. of employees
11K
About Dimed SA Distribuidora de Medicamentos
CEO-
Employees11.5K
Founded1920
Headquarters-
SectorDrug
Websitegrupopanvel.com.br
Last report
Aug 7, 2026
Fiscal period
Q2 2026
EPS / Est. (BRL)
R$0.26 / R$0.27
-4.41%miss
Revenue / Est. (BRL)
1.51B / 1.61B
-6.47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.37B
1.57B
1.45B
1.51B
Cost of goods sold
934.42M
1.03B
895.86M
1.02B
Cost of revenue
934.42M
1.03B
895.86M
1.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374.10M
447.70M
398.26M
434.04M
Operating expense
369.24M
460.93M
486.17M
427.45M
Total operating expenses
1.30B
1.49B
1.38B
1.44B
Operating income
70.33M
78.49M
67.63M
66.48M
Other non operating income
-4.39M
-6.17M
-3.34M
9.66M
EBT including unusual items
41.77M
46.89M
37.18M
35.36M
EBT excluding unusual items
42.82M
48.39M
36.64M
35.36M
Income tax expense
10.47M
4.14M
3.94M
4.99M
Effective tax rate
25.07%
8.83%
10.61%
14.11%
Other operating expenses
-4.86M
13.23M
87.91M
-6.60M
Net income
31.30M
42.75M
33.23M
30.37M
Net profit margin
2.28%
2.73%
2.29%
2.01%
Earnings per share
-
-
-
0.26
Interest and investment income
10.22M
14.55M
12.28M
-
Interest expense
-33.34M
-38.48M
-39.93M
-40.78M
Net interest expenses
-23.12M
-23.93M
-27.65M
-40.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
87.05M
95.46M
84.75M
173.81M
Gain or loss from assets sale
-
-
-2.92M
3.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps